News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
90,678 Results
Type
Article (6651)
Company Profile (41)
Press Release (83986)
Section
Business (27711)
Career Advice (125)
Deals (3993)
Drug Delivery (30)
Drug Development (14094)
Employer Resources (12)
FDA (2830)
Job Trends (2107)
News (49174)
Policy (5995)
Tag
Academia (421)
Allergies (21)
Alliances (8933)
Alzheimer's disease (234)
Antibody-drug conjugate (ADC) (24)
Approvals (2812)
Artificial intelligence (21)
Bankruptcy (18)
Best Places to Work (1776)
BIOSECURE Act (15)
Biosimilars (52)
Biotechnology (29)
Breast cancer (22)
Cancer (220)
Career advice (108)
Cell therapy (47)
Clinical research (11146)
Collaboration (84)
Compensation (17)
COVID-19 (528)
C-suite (23)
Data (215)
Diabetes (20)
Diagnostics (504)
Drug pricing (15)
Earnings (9201)
Events (11495)
Executive appointments (40)
FDA (2974)
Funding (60)
Gene therapy (50)
GLP-1 (96)
Government (1288)
Healthcare (1940)
Immunology and inflammation (19)
Infectious disease (545)
Inflammatory bowel disease (40)
IPO (1824)
Job creations (385)
Job search strategy (106)
Layoffs (48)
Legal (556)
Lung cancer (52)
Manufacturing (67)
Medical device (1158)
Medtech (1159)
Mergers & acquisitions (2212)
Metabolic disorders (45)
Neuroscience (275)
NextGen Class of 2024 (697)
Non-profit (345)
Northern California (273)
Obesity (16)
Opinion (39)
Patents (13)
Peanut (18)
People (7821)
Phase I (3651)
Phase II (4643)
Phase III (4084)
Pipeline (120)
Policy (27)
Postmarket research (293)
Preclinical (1436)
Press Release (66)
Radiopharmaceuticals (35)
Rare diseases (32)
Real estate (911)
Regulatory (4550)
Research institute (386)
Southern California (284)
Startups (571)
United States (2408)
Vaccines (140)
Date
Today (44)
Last 7 days (203)
Last 30 days (671)
Last 365 days (6553)
2024 (5922)
2023 (6960)
2022 (9060)
2021 (9479)
2020 (8176)
2019 (5871)
2018 (4526)
2017 (5071)
2016 (4635)
2015 (5295)
2014 (3721)
2013 (2897)
2012 (2990)
2011 (3147)
2010 (2576)
Location
Africa (91)
Asia (7311)
Australia (864)
California (629)
Canada (154)
China (91)
Colorado (23)
Delaware (16)
Europe (13565)
Florida (67)
Idaho (13)
Illinois (30)
Indiana (25)
Maryland (226)
Massachusetts (419)
Minnesota (37)
New Jersey (269)
New York (173)
North Carolina (146)
Northern California (273)
Ohio (27)
Pennsylvania (114)
South America (134)
Southern California (284)
Texas (71)
Washington State (53)
90,678 Results for "mtf biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
MTF Biologics and Centurion Therapeutics Partner to Expand Access to Advance Wound Care Technologies
MTF Biologics and Centurion Therapeutics announced they have entered into a new agreement that will give more clinicians and patients in complex wound settings within hospitals and post-acute care facilities access to advanced wound healing technologies.
June 13, 2024
·
4 min read
FDA
MTF Biologics® Receives First Investigational Device Exemption Approval for Human Acellular Dermal Matrix in Breast Reconstruction
MTF Biologics ® Receives First Investigational Device Exemption Approval for Human Acellular Dermal Matrix in Breast Reconstruction.
October 24, 2023
·
3 min read
Pharm Country
MTF Biologics Awards 2022 Extramural Research Grants
MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, has awarded more than $850,000 in funding to seven researchers across the nation through its 2022 Extramural Research Grants Program.
January 11, 2023
·
3 min read
Pharm Country
MTF Biologics Unveils New Tissue Form: AlloPatch® Pliable Meshed - Acellular Human Reticular Dermal Allograft
MTF Biologics, a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients, and advancing the science of tissue transplantation, is introducing AlloPatch® Pliable Meshed to its line of premier, innovative and effective wound care solutions.
April 17, 2023
·
4 min read
Genetown
Bone Biologics Enters into Supply Agreement with MTF Biologics for Demineralized Bone Matrix
Bone Biologics Corporation announces it has entered into a supply agreement with MTF Biologics for demineralized bone matrix (DBM).
March 7, 2022
·
4 min read
News
Webinar: Revolutionizing Biologics Discovery: Harnessing the Power of AI and Patent Data
This webinar explores the pivotal role of patent data in overcoming the data challenges faced by generative AI models in drug discovery, particularly for biologics. Watch now.
October 23, 2024
·
1 min read
·
BioSpace Insights
Business
Orthofix and MTF Biologics Expand Partnership Agreement
Orthofix Medical Inc today announced the renewal and expansion of its partnership agreement with MTF Biologics – a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients and advancing science.
May 3, 2022
·
6 min read
Approvals
AstraZeneca Wins Rare Autoimmune Indication for Asthma Biologic Fasenra
With the FDA’s approval, Fasenra will compete with GSK’s Nucala, which in December 2017 became the first biologic approved for eosinophilic granulomatosis with polyangiitis.
September 19, 2024
·
2 min read
·
Tristan Manalac
BIOSECURE Act
WuXi Biologics Faces Uncertain Future in the U.S. After BIOSECURE Blow
WuXi AppTec looks to unload its Philadelphia manufacturing sites and WuXi Biologics slows its rapid expansion in the U.S. as the companies await the Senate’s review of the BIOSECURE Act that threatens to cut them off from U.S. biopharma.
October 8, 2024
·
5 min read
·
Ben Hargreaves
Press Releases
Biologics Market Size to Reach USD 699.5 Billion by 2032, Impelled by Emergence of Advanced Drug Delivery Systems
Biologics Market Outlook 2024-2032:
August 8, 2024
·
14 min read
1 of 9,068
Next
